Interactions on record — worth a quick check against your medications. Based on 3 of 5 ingredients. Check your meds →
Dietary supplement

Yum-Yum Dophilus 1 Billion CFU Raspberry Ingredients & Drug Interactions

by Jarrow Formulas

Yum-Yum Dophilus 1 Billion CFU Raspberry label
See full label image
Tablet Or Pill Category: Other Combinations
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Oct 7, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Yum-Yum Dophilus 1 Billion CFU Raspberry against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Yum-Yum Dophilus 1 Billion CFU Raspberry is a dietary supplement by Jarrow Formulas with 5 active ingredients. Its ingredients are commonly taken for digestive health and regularity, infant colic and gut support, diarrhea (including antibiotic-related).Based on those ingredients, 268 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Bifidobacterium breve BR-03, Lactobacillus acidophilus LA-02, Inulin. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas

Ask about any prescription or over-the-counter medication and we check it for interactions with Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Oct 8, 2026

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 1 of its 5 active ingredients.
  • “Proprietary Probiotic Blend” is a proprietary blend — the label gives one combined amount (5 mg) without saying how much of each component you get.

The active ingredients are a proprietary probiotic blend, inulin, Bifidobacterium breve BR-03, Lactobacillus acidophilus LA-02, Bifidobacterium lactis BS-01, and Lactobacillus plantarum LP-01. Inulin is a fiber, and the probiotic strains are live bacteria.

The blend is listed as a group, with its component ingredients named individually. The inactive ingredients include xylitol, microcrystalline cellulose, maltodextrin, stearic acid, natural flavor, magnesium stearate, glycerin fatty acid esters, beet powder, silicon dioxide, monk fruit extract, and citric acid.

These are fillers, binders, and similar supporting ingredients.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed

This product doesn't appear to be marketed for a specific use, so we graded its ingredients' overall clinical evidence instead.

Moderate

Some clinical evidence supports its ingredients for:

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.
  • Since the label doesn't commit to one use, we graded the ingredients' overall clinical evidence instead.
  • On file: Antibiotic-associated diarrhea — rated "Possibly Effective" (Lactobacillus Acidophilus) (Natural Medicines).
  • On file: Bacterial vaginosis — rated "Possibly Effective" (Lactobacillus Acidophilus) (Natural Medicines).
  • On file: Helicobacter pylori — rated "Possibly Effective" (Lactobacillus Acidophilus) (Natural Medicines).
  • On file: Irritable bowel syndrome (IBS) — rated "Possibly Effective" (Lactobacillus Acidophilus) (Natural Medicines).
  • On file: Constipation — rated "Possibly Effective" (Inulin) (Natural Medicines).

For inulin, the data rates it possibly effective for obesity, diabetes, and constipation. The evidence is insufficient to rate it for alcohol use disorder and nonalcoholic fatty liver disease (NAFLD).

For Bifidobacterium breve BR-03, the data rates it possibly ineffective for age-related cognitive decline and sepsis, and the evidence is insufficient to rate it for allergic rhinitis (hay fever) and antibiotic-associated diarrhea. For Lactobacillus acidophilus LA-02, the data rates it possibly effective for Helicobacter pylori, bacterial vaginosis, antibiotic-associated diarrhea, and irritable bowel syndrome (IBS), possibly ineffective for atopic disease, and insufficient to rate for allergic rhinitis.

We hold no effectiveness ratings for the other ingredients.

The evidence, ingredient by ingredient Bifidobacterium Breve Lactobacillus Acidophilus Inulin

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 3 of 3.
  • General safety write-ups exist for 3 of 3.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Inulin is generally well tolerated in food amounts, but it often causes gas and bloating, especially at higher doses. Its listed adverse effects include bloating, constipation, diarrhea, gas, and stomach cramps, with more reports at doses over 30 grams.

Anaphylaxis (a severe allergic reaction) has occurred rarely after eating foods high in inulin. Bifidobacterium breve BR-03 is generally well tolerated in healthy people, but caution is needed for those who are very ill or immunocompromised, and rare cases of bacteremia (bacteria in the blood) have been reported in critically ill or preterm patients.

Lactobacillus acidophilus LA-02 is generally well tolerated in healthy adults and children, though stomach side effects such as gas and diarrhea are reported as uncommon. Pregnancy data for inulin is rated likely safe, and for B. breve and L. acidophilus it is rated possibly safe for pregnancy.

No lactation data is on file for the two probiotic strains, so talk with your doctor or pharmacist about your personal situation.

Side effects, ingredient by ingredient Bifidobacterium Breve Lactobacillus Acidophilus Inulin

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 3 of the 3 matched ingredients can interact with medications — Lactobacillus Acidophilus, Inulin, Bifidobacterium Breve.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: diabetes medications.
  • For scale: 268 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Antibiotic drugs are the medication type to double-check first, with a Moderate interaction, because antibiotics may reduce the effectiveness of the live probiotic bacteria. Antidiabetes drugs carry a Minor interaction because inulin may theoretically increase the risk of low blood sugar.

Several other ingredients could not be checked, so confirm your full medication list with your own doctor or pharmacist.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence behind its ingredients' uses. Moderate medication interactions have been identified, and safety information is well characterized.

This product may suit adults looking for a probiotic and fiber combination, particularly if they have a rating-supported goal such as constipation. If you are taking antibiotics, have diabetes or take antidiabetes drugs, are very ill or immunocompromised, or are pregnant or breastfeeding, be more careful and talk it over with your own doctor or pharmacist before starting.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 3 of 5 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated May 23, 2024.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Yum-Yum Dophilus 1 Billion CFU Raspberry, straight from the product label.

Brand Jarrow Formulas
Barcode (UPC) 790011030218
Net contents 60 Chewable Tablet(s)
Market status On market
Date entered into DSLD May 23, 2024
DSLD ID 307750
Product type Other Combinations
Supplement form Tablet Or Pill
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Children 4 or More Years of Age, Vegan, Vegetarian, Adult (18 - 50 Years), No Allergies, Gluten Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
2 Chewable Tablet(s)
Maximum serving Sizes:
4 Chewable Tablet(s)
Servings per container
30
UPC/BARCODE
790011030218
IngredientAmount% DV
Proprietary Probiotic Blend5 mg--
Inulin100 mg--
Bifidobacterium breve BR-030 NP--
Lactobacillus acidophilus LA-020 NP--
Bifidobacterium lactis BS-010 NP--
Lactobacillus plantarum LP-010 NP--

Other ingredients: Xylitol, Microcrystalline Cellulose, Maltodextrin, Stearic Acid, Natural flavor, Magnesium Stearate, Glycerin Fatty Acid Esters, Beet, Powder, Silicon Dioxide, Monk Fruit Extract, Citric Acid

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts, or sesame. Sugar Free No Synthetic dyes, artificial sweeteners or flavors.

Strains Matter When it comes to effective probiotics clinically documented Strains Matter. As an innovator of consumer probiotics since 1986, Jarrow Formulas takes great pride in using high-quality and scientifically documented strains that have been developed through years of research and innovation.

Vegan

Daily Gut Balance Helps maintain gut health and supports the immune system

Gluten Free

Beneficial intestinal flora can be negatively affected or reduced by a diet that is low in fiber or high in animal protein, or travel and stress. The result is disruption of the intestinal microflora that can impact digestive function and well-being. The friendly bacteria in Yum-Yum Dophilus help maintain a balanced intestinal microflora, support the immune system, and promote health. Each tablet is individually blister packed for enhanced stability and convenience.

Live Probiotic Guarantee

Formula

Xylitol used to enhance the taste

Raspberry and other natural flavors 4 Clinically studied strains

Jarrow Formulas Yum-Yum Dophilus provides 4 clinically documented strains of beneficial bacteria in a yummy chewable tablet.

Storage

Blister packed Protects probiotic bacteria from moisture and oxygen for superior stability.

Keep refrigerated.

When kept under recommended storage conditions, Jarrow Probiotics are formulated to ensure CFU counts are guaranteed within Best Used Before date. Keep Refrigerated

Suggested/Recommended/Usage/Directions

Suggested Use: Take 2 chewable tablets once a day, during or shortly after a meal. Recommended for children age 2 and above under the supervision of a parent or caregiver. May take up to 4 tablets a day or as directed by your qualified healthcare professional.

Precautions

Warning: Consult a healthcare professional before using this product if your child has a medical condition; if adverse reactions occur, discontinue use.

Warning: Consult a healthcare professional before using this product if your child has a medical condition; if adverse reactions occur, discontinue use. Keep out of the reach of children.

Do not use if safety seal or blister is broken, damaged or missing.

Seals/Symbols

IPRO

Igen Non-GMO Tested

Brand IP Statement(s)

Copyright 2023 Jarrow Formulas

FDA Statement of Identity

Probiotics Supplement

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

General Statements

Probiotics

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Yum-Yum Dophilus 1 Billion CFU Raspberry label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas

These are the 5 active ingredients this product is made of. Select any to open its full monograph.

Serving size2 Chewable Tablet(s) Dosage formTablet Or Pill Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Proprietary Probiotic Blend

5 mg per serving

Inulin

Interacts with
86 drugs
100 mg per serving Form: Fructooligosaccharides

Inulin is a type of plant fiber (a prebiotic) found naturally in foods like chicory root, onions, and garlic, and it is widely added to supplements an...

Inulin monograph & interactions

Other (inactive) ingredients: Xylitol, Microcrystalline Cellulose, Maltodextrin, Stearic Acid, Natural flavor, Magnesium Stearate, Glycerin Fatty Acid Esters, Beet, Powder, Silicon Dioxide, Monk Fruit Extract, Citric Acid. These complete the product’s ingredient list but are not active constituents.

Interaction report

Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas Drug Interactions

Want to check YOUR meds against Yum-Yum Dophilus 1 Billion CFU Raspberry?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
268Drugs
182 Moderate 86 Minor

Ingredients driving the most interactions

Bifidobacterium breve BR-03 182
Lactobacillus acidophilus LA-02 182
Inulin 86

Individual Drug Interactions

The ingredients in Yum-Yum Dophilus 1 Billion CFU Raspberry interact with 268 drugs. Click any drug to see the details.

3 of the 5 ingredients in Yum-Yum Dophilus 1 Billion CFU Raspberry interact with drugs. Each result below shows which ingredient is responsible. Bifidobacterium breve BR-03 Lactobacillus acidophilus LA-02 Inulin

Each ingredient & the kinds of drugs it affects

For each ingredient in Yum-Yum Dophilus 1 Billion CFU Raspberry with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Bifidobacterium breve BR-031 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bifidobacterium breve with antibiotic drugs might decrease the effectiveness of B. breve.
Since B. breve preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. breve preparations by at least 2 hours.

Likelihood Probable Evidence D
Bifidobacterium breve BR-03 full monograph & interactions

Lactobacillus acidophilus LA-021 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Lactobacillus acidophilus with antibiotic drugs might decrease the effectiveness of L. acidophilus.
L. acidophilus preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. acidophilus preparations by at least two hours.

Likelihood Probable Evidence D
Lactobacillus acidophilus LA-02 full monograph & interactions

Inulin1 drug type · 86 drugs

Antidiabetes Drugs

Theoretically, inulin might increase the risk of hypoglycemia with antidiabetes drugs.
Some clinical research shows that inulin improves glycemic control in patients with diabetes; however, it is unclear if it has hypoglycemic effects.

Likelihood Unlikely Evidence D
Inulin full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Yum-Yum Dophilus 1 Billion CFU Raspberry, from the product label.

Jarrow Formulas

See all Jarrow Formulas products
Name
Jarrow Formulas, Inc.
City
Sherman Oaks
State
CA
ZipCode
91403
Phone Number
1-866-459-4154
Web Address
www.Jarrow.com
Pharmacist Counseling Corner

Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas: Common Questions

Does Yum-Yum Dophilus 1 Billion CFU Raspberry by Jarrow Formulas interact with any medications?
Yes. Based on its ingredients, Yum-Yum Dophilus 1 Billion CFU Raspberry has a known interaction with 268 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Yum-Yum Dophilus 1 Billion CFU Raspberry contains 5 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is inulin safe during pregnancy?
The pregnancy and lactation data for inulin is rated likely safe. Talk with your own doctor or pharmacist to decide whether it fits your situation.
Does this product help with constipation?
Inulin is rated possibly effective for constipation, which means the evidence leans positive but is not firmly established. Your results may vary.
What side effects does inulin commonly cause?
Inulin commonly causes bloating, gas, constipation, diarrhea, and stomach cramps. These are reported more often at doses over 30 grams.
Can I take the probiotic strains during pregnancy?
Bifidobacterium breve BR-03 and Lactobacillus acidophilus LA-02 are both rated possibly safe in pregnancy. Their lactation data is not on file, so please talk with your doctor or pharmacist for personalized advice.
Does Lactobacillus acidophilus help with irritable bowel syndrome?
Lactobacillus acidophilus LA-02 is rated possibly effective for irritable bowel syndrome (IBS). The evidence is suggestive but not firmly established.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Yum-Yum Dophilus 1 Billion CFU Raspberry is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Yum-Yum Dophilus 1 Billion CFU Raspberry label
Go deeper

The Full Monographs Behind Yum-Yum Dophilus 1 Billion CFU Raspberry’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Bifidobacterium Breve

Interacts with 182 drugs

Bifidobacterium breve is a 'friendly' gut bacterium taken as a probiotic, most often to support digestion and balance the gut microbiome. Some studies suggest possible benefits for certain d...

Read the full Bifidobacterium Breve monograph → Herb & supplement monograph

Lactobacillus Acidophilus

Interacts with 182 drugs

Lactobacillus acidophilus is a 'friendly' bacterium used as a probiotic to support gut and vaginal health. It is generally well tolerated in healthy people, and there is reasonable evidence...

Read the full Lactobacillus Acidophilus monograph → Herb & supplement monograph

Inulin

Interacts with 86 drugs

Inulin is a type of plant fiber (a prebiotic) found naturally in foods like chicory root, onions, and garlic, and it is widely added to supplements and processed foods. It may help with regu...

Read the full Inulin monograph →
Sources

Sources & How We Checked

Yum-Yum Dophilus 1 Billion CFU Raspberry's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 42 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Inulin 18 references
  1. Williams CM. Effects of inulin on lipid parameters in humans. J Nutr 1999 Jul;129(7 Suppl):1471S-3S. PubMed
  2. Pedersen A, Sandstrom B, Van Amelsvoort JM. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 1997;78:215-22. PubMed
  3. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr 2001;73:415S-420S. PubMed
  4. Bonnema AL, Kolberg LW, Thomas W, Slavin JL. Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc 2010;110(6):865-8. PubMed
  5. Dehghan P, Gargari BP, Jafar-Abadi MA, Aliasgharzadeh A. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial. Int J Food Sci Nutr 2014;65(1):117-23. PubMed
  6. Guess ND, Dornhorst A, Oliver N, Frost GS. A randomised crossover trial: the effect of inulin on glucose homeostasis in subtypes of prediabetes. Ann Nutr Metab 2016;68(1):26-34. PubMed
  7. Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr 2011;62(2):164-70. PubMed
  8. Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WL. Inulin, a flexible oligosaccharide I: review of its physicochemical characteristics. Carbohydr Polym 2015;130:405-19. PubMed
  9. Slavin J, Feirtag J. Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct. 2011;2(1):72-7. PubMed
  10. Micka A, Siepelmeyer A, Holz A, Theis S, Schön C. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. Int J Food Sci Nutr. 2017;68(1):82-89. PubMed
  11. Smiljanec K, Mitchell CM, Privitera OF, Neilson AP, Davy KP, Davy BM. Pre-meal inulin consumption does not affect acute energy intake in overweight and obese middle-aged and older adults: A randomized controlled crossover pilot trial. Nutr Health. 2017;23 PubMed
  12. Cai X, Yu H, Liu L, et al. Milk powder co-supplemented with inulin and resistant dextrin improves glycemic control and insulin resistance in elderly type 2 diabetes mellitus: a 12-week randomized, double-blind, placebo-controlled trial. Mol Nutr Food Res PubMed
  13. Rao M, Gao C, Xu L, et al. Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis. J Diabetes Res. 2019;2019:5101423. PubMed
  14. Mitchell CM, Davy BM, Ponder MA, et al. Prebiotic Inulin Supplementation and Peripheral Insulin Sensitivity in adults at Elevated Risk for Type 2 Diabetes: A Pilot Randomized Controlled Trial. Nutrients 2021;13(9):3235. PubMed
  15. Li L, Li P, Xu L. Assessing the effects of inulin-type fructan intake on body weight, blood glucose, and lipid profile: A systematic review and meta-analysis of randomized controlled trials. Food Sci Nutr 2021;9(8):4598-4616. PubMed
  16. Ziaei R, Shahshahan Z, Ghasemi-Tehrani H, Heidari Z, Ghiasvand R. Effects of inulin-type fructans with different degrees of polymerization on inflammation, oxidative stress and endothelial dysfunction in women with polycystic ovary syndrome: A randomized,
  17. Risso D, Kaczmarczyk M, Laurie I, et al. Moderate intakes of soluble corn fibre or inulin do not cause gastrointestinal discomfort and are well tolerated in healthy children. Int J Food Sci Nutr 2022;73(8):1104-1115. PubMed
  18. Isakov VA, Pilipenko VI, Vlasova AV, Kochetkova AA. Evaluation of the efficacy of kombucha-based drink enriched with inulin and vitamins for the management of constipation-predominant irritable bowel syndrome in females: A randomized pilot study. Curr Dev PubMed

See these in context on the Inulin monograph →

Bifidobacterium Breve 9 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  3. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  4. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81. PubMed
  5. Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
  6. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  7. Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
  8. Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667. PubMed
  9. Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014;28:1-3. PubMed

See these in context on the Bifidobacterium Breve monograph →

Lactobacillus Acidophilus 15 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35 PubMed
  3. Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
  4. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
  5. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 2016;42(4):234-41. PubMed
  6. Badehnoosh B, Karamali M, Zarrati M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018 May;31(9):1128-1136.
  7. Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabete
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Xiao SD, Zhang DZ, Lu H, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60.
  10. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  11. Ozer M, Goksu SY, Shahverdiani A, Mustafa M. Lactobacillus acidophilus-induced endocarditis and associated splenic abscess. Case Rep Infect Dis 2020;2020:1382709.
  12. Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540. PubMed
  13. Stoffer JN, Slingsby TJ, Giuliari GP. Lactobacillus acidophilus endophthalmitis after intravitreal bevacizumab injection requiring intraocular lens explantation. Can J Ophthalmol 2022;57(1):e21-e22. PubMed
  14. Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 2006;73(2-3):107-10.
  15. Hui J, Ren Y, Wang Y, Han Q. Lactobacillus acidophilus endophthalmitis postcataract operation: A case report with a literature review. Ocul Immunol Inflamm 2023.

See these in context on the Lactobacillus Acidophilus monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team